Latest News About Scalp–Ear–Nipple Syndrome

Here’s the latest high-level update on Scalp–ear–nipple syndrome (SENS) based on current reputable sources.

• What it is now: Scalp–ear–nipple syndrome is a rare, autosomal dominant genetic condition classically described by a triad of scalp aplasia cutis congenita (scalp hairless areas present at birth), hypoplastic or prominent ears, and amastia or nipple hypoplasia. Additional features can include renal/urinary abnormalities and cataracts in some individuals. The condition has been referred to by several names, including Finlay–Marks syndrome and SENS, reflecting historical descriptions.[5][6][7][9]
• How often it’s described: To date, only dozens of cases have been reported in the literature, highlighting its rarity and the importance of genetic evaluation and multidisciplinary care for affected families.[6][5]
• Genetic basis: Mutations in the KCTD1 gene are a known cause in many reported cases, supporting autosomal dominant inheritance with variable expressivity. Numerous case reports and reviews discuss genotype–phenotype correlations and the spectrum of anomalies observed in SEN/SENS.[2][3][5][6]
• Diagnosis and management: Diagnosis is clinical supported by genetic testing (panel or targeted sequencing for KCTD1 and related genes). Management typically involves a multidisciplinary team to address scalp healing, ear/anatomical considerations, and breast/nipple development, with surgical options considered for reconstructive needs when appropriate. Ongoing follow-up is common due to potential associated anomalies (renal, ocular) and developmental considerations in some cases.[7][2][5]
• Recent resources and guidance: National and international rare-disease information portals (GARD/NIH, MedlinePlus Genetics, Orphanet) provide up-to-date clinician-oriented summaries, inheritance patterns, and links to patient support networks; these sites are routinely updated as new case data emerges.[10][6][7]

Illustrative example

• A patient presents at birth with a hairless patch on the scalp, small or underdeveloped external ears, and nipple hypoplasia or absence. Genetic testing may reveal KCTD1-related variants, guiding counseling on inheritance and highlighting the need for targeted surveillance for possible renal or ocular issues. Multidisciplinary care including dermatology, ENT/otolaryngology, plastic surgery, nephrology, and genetics is often beneficial.[2][5][7]

If you’d like, I can compile a brief, cited one-page overview for families or clinicians, or summarize the latest case counts and recommended surveillance plans from current patient organizations and reviews.